Rhode Island Chronicle

Smoking Cessation Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies – Axsome Therapeutics, Achieve Life Sciences, Chronic Airway Therapeutics

 Breaking News
  • No posts were found

Smoking Cessation Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies – Axsome Therapeutics, Achieve Life Sciences, Chronic Airway Therapeutics

September 26
07:56 2023
Smoking Cessation Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies - Axsome Therapeutics, Achieve Life Sciences, Chronic Airway Therapeutics
Smoking Cessation Market
DelveInsight’s “Smoking Cessation Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Smoking Cessation, historical and forecasted epidemiology as well as the Smoking Cessation market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight has launched a new report on Smoking Cessation – Market Insights, Epidemiology, and Market Forecast-2032”.

Some of the key facts of the Smoking Cessation Market Report:

  • As per DelveInsight analysts, the total diagnosed prevalent population of Smoking Cessation in the 7MM was 50,426,314 in 2020
  • Among the European-5 countries, Germany had the highest diagnosed prevalent population of smokers with 18,644,546 cases, followed by France with 13,800,471 cases. On the other hand, the United Kingdom had the lowest diagnosed prevalent population of 7,251,487 in 2020.
  • Out of the total 33,625,322 diagnosed prevalent cases of smokers in the US, the highest cases were observed in 45–64 years (13,416,503) and the least cases were observed in 18-24 years (2,992,654) in the year 2020.

Key benefits of the report:

  1. Smoking Cessation market report covers a descriptive overview and comprehensive insight of the Smoking Cessation Epidemiology and Smoking Cessation  market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Smoking Cessation market report provides insights on the current and emerging therapies.
  3. Smoking Cessation market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Smoking Cessation market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Smoking Cessation market.

Smoking Cessation Overview

Smoking cessation is the process of discontinuing tobacco smoking. When a person smokes tobacco in cigarettes, cigars, or pipes, they absorb toxins that can lead to various health problems such as diabetes, cancer, chronic obstructive pulmonary disease (COPD), heart diseases, lung diseases, etc.

The main barrier to smoking cessation is nicotine addiction. Some of the most common nicotine withdrawal symptoms smokers face when they try to quit smoking include craving for smoking, mood swings, insomnia, constipation, increased appetite, anxiety, etc.

Smoking Cessation Market 

The dynamics of the Smoking Cessation market are anticipated to change in the coming years owing to the expected launch of emerging therapies by companies such as Axsome Therapeutics, Achieve Life Sciences, Chronic Airway Therapeutics, Smoke-Free Therapeutics (NFL Biosciences SAS),  Novo Nordisk, and others during the study period 2019-2032.

Smoking Cessation Pipeline Therapies and Key Companies 

  • AXS-05: Axsome Therapeutics
  • Cytisinicline: Achieve Life Sciences
  • Nadolol (INV102): Chronic Airway Therapeutics
  • NFL-101: Smoke-Free Therapeutics (NFL Biosciences SAS)
  • Liraglutide: Novo Nordisk
  • And others.

Smoking Cessation Market Drivers 

  • Research and Development
  • Increase in awareness 
  • Government-mandated warnings on tobacco products 

Table of Contents

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Smoking Cessation Patient Share (%) Overview at a Glance

5. Smoking Cessation Market Overview at a Glance

6. Smoking Cessation Disease Background and Overview

7. Smoking Cessation Epidemiology and Patient Population

8. Country-Specific Patient Population of Smoking Cessation 

9. Smoking Cessation Current Treatment and Medical Practices

10. Unmet Needs

11. Smoking Cessation Emerging Therapies

12. Smoking Cessation Market Outlook

13. Country-Wise Smoking Cessation Market Analysis (2019–2032)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Smoking Cessation Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Related Reports:

Smoking Cessation Pipeline 

“Smoking Cessation Pipeline Insight, 2023” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Smoking Cessation market. A detailed picture of the Smoking Cessation pipeline landscape is provided, which includes the disease overview and Smoking Cessation treatment guidelines.

Smoking Cessation Epidemiology

DelveInsight’s ‘Smoking Cessation Epidemiology Forecast to 2032’ report delivers an in-depth understanding of the disease, historical and forecasted Smoking Cessation epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: +91-9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Categories